[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"patient\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:patient":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,49,75,103],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":30,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":5},"100637389","the-effect-of-progressive-muscle-relaxation-and-deep-breathing-exercises-applied-to-palliative-care-cancer-patients-on-dyspnea-fatigue-and-self-care-behaviors-100637389",false,"NCT07619209","The Effect of Progressive Muscle Relaxation and Deep Breathing Exercises Applied to Palliative Care Cancer Patients on Dyspnea, Fatigue, and Self-Care Behaviors","Inclusion Criteria:\n\n* Being 18 years of age or older\n\nBeing literate (able to read and write)\n\nHaving no significant hearing or visual impairment that prevents communication or cooperation\n\nReceiving treatment in the palliative care unit\n\nHaving a confirmed medical diagnosis of cancer\n\nHaving a Glasgow Coma Scale (GCS) score of 10 or higher\n\nBeing able to communicate via telephone and SMS for post-discharge follow-up\n\nHaving a Common Terminology Criteria for Adverse Events (CTCAE) Dyspnea Classification of Grade 3 or below\n\nHaving an ECOG Performance Status Scale score of 3 or below\n\nHaving a Hemoglobin (Hb) value of 8 gm\u002FdL or higher\n\nVolunteering to participate in the study and providing informed consent\n\nExclusion Criteria:\n\n* Currently practicing or having recently practiced Progressive Muscle Relaxation (PMR) or deep breathing exercises actively\n\nHaving a primary respiratory system disease diagnosis (such as COPD, asthma, or pneumonia)\n\nHaving a medical diagnosis of dementia, agitation, or delirium\n\nReceiving Continuous Positive Airway Pressure (CPAP) or Bilevel Positive Airway Pressure (BiPAP) support\n\nBeing on active antipsychotic or sedative medical treatment\n\nHaving a Common Terminology Criteria for Adverse Events (CTCAE) Dyspnea Classification of Grade 4 or higher","ALL","18 Years",{"count":18,"type":19},90,"ESTIMATED","INTERVENTIONAL",[22],"NA","The purpose of this study is to evaluate the effects of Progressive Muscle Relaxation (PMR) exercises and deep breathing exercises on dyspnea, fatigue, and self-care behaviors among cancer patients receiving palliative care. Advanced-stage cancer patients frequently experience debilitating symptoms such as shortness of breath (dyspnea) and severe fatigue, which significantly impair their functional capacity and daily self-care activities. Participants in this study will be assigned to either a progressive muscle relaxation intervention group or a structured deep breathing exercise group. The study aims to determine whether these non-pharmacological relaxation techniques can effectively reduce the severity of dyspnea and fatigue, thereby improving the patients' overall self-care behaviors and physical comfort in a palliative care setting.",[25,26,27,28,29],"Cancer","Fatigue","Palliative Care","Progressive Muscle Relaxation","Patient",[27,31,28,32,33,34,35,36],"Cancer Patients","Deep Breathing Exercises","Dyspnea Management","Cancer-Related Fatigue","Self-Care Behaviors","Randomized Controlled Trial","RECRUITING","2026-05-30",{"date":40,"type":41},"2026-06-03","ACTUAL",{"date":43,"type":41},"2026-01-01",{"date":45,"type":19},"2026-12",{"name":47,"class":48},"Ankara University","OTHER",{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":15,"minAge":57,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":20,"phases":60,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100628761","prospective-multicentre-study-for-the-application-of-telomere-measurement-technology-as-a-tool-for-lung-cancer-diagnosis-100628761","NCT07465848","Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis","PneumoTAV001","Inclusion Criteria:\n\nCase Group:\n\n* Person aged 45 years or older at the time of signing the consent form.\n* Person with a current anatomopathologically confirmed diagnosis of small-cell or non-small cell lung cancer.\n* Not having received any oncological treatment prior to sample collection (surgery, radiotherapy, or systemic treatment with chemotherapy or immunotherapy).\n\nControl Group:\n\nCohort A (High risk controls):\n\n* Person aged 45 years or older at the time of signing the consent form.\n* High risk of lung cancer, defined as having a smoking history of at least 20 pack-year and currently smoking or having quit within the past 15 years.\n* No diagnosis or suspicion of lung cancer. Asymptomatic individuals who have undergone a chest computed tomography (CT) scan for lung cancer screening within the 12 months prior to signing the informed consent and as part of routine clinical practice, with a LUNG-RADS score of 3 or lower, will be included.\n\nCohort B (Low-risk controls):\n\n* Person aged 45 years or older at the time of signing the consent form.\n* Without high risk of lung cancer according to the criteria defined in cohort A.\n* No diagnosis or suspicion of lung cancer.\n\nExclusion Criteria:\n\n* History of any malignant neoplasm, except for subjects with tumors in localized stages who have undergone radical treatment and have been disease-free for at least five years.\n* Patient diagnosed with lung cancer who has already started oncological treatment before sample collection.\n* Patient who has undergone a biopsy or any invasive procedure or minor surgery less than 48 hours ago.\n* Patient who has undergone major surgery less than 7 days ago.\n* Patient with severe chronic kidney disease, defined as a glomerular filtration rate below 15 ml\u002Fmin.\n* Patient with severe liver disease, defined as Child-Pugh C.\n* Active infection, or treated less than 4 weeks ago.\n* Vulnerable population, for example, minors, prisoners, pregnant women, adults physically or mentally incapable of giving consent.",true,"45 Years",{"count":59,"type":19},1200,[22],"This research is a clinical performance study of in vitro diagnostic device (IVD), a prospective, multicentre, open-label, case-control clinical investigation aimed at constructing a predictive model that allows results to be classified as positive or negative in relation to the probability of having lung cancer.",[63,64,29],"Lung Cancer (Diagnosis)","Health Adult Subjects","2026-03-09",{"date":67,"type":41},"2026-03-12",{"date":69,"type":41},"2025-10-08",{"date":71,"type":19},"2026-12-31",{"name":73,"class":48},"Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)",12,{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":20,"phases":84,"briefSummary":85,"conditions":86,"keywords":89,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":102},"100556444","ai-as-an-aid-for-weekly-symptom-intake-in-radiotherapy-100556444","NCT06525181","AI as an Aid for Weekly Symptom Intake in Radiotherapy","Evaluation of AI-Enhanced Symptom Summarization in Weekly Radiotherapy Consultations: A Comparative Study","Inclusion Criteria:\n\nAll patients undergoing radiotherapy in the pelvic region.\n\nExclusion Criteria:\n\nCases of pelvic reirradiation or operated cases.",{"count":83,"type":19},200,[22],"The study investigates the use of artificial intelligence (AI) and large language models (LLMs) to enhance the efficiency and accuracy of weekly treatment consultations (OTVs) in radiotherapy. It hypothesizes that an AI-enabled symptom summary tool will match traditional medical review methods in accuracy while saving time. The study includes patients undergoing pelvic radiotherapy and excludes those with pelvic reirradiation or who have undergone surgery. Patients will receive both standard and AI-assisted weekly consultations, with AI summaries generated using the OpenAI GPT-4 API. Blinded oncologists will compare the accuracy and quality of the AI-generated and doctor-generated summaries, while patients and doctors will rate these summaries. The primary objective is to evaluate the accuracy and time efficiency of AI-assisted symptom summaries compared to traditional methods.",[87,88,29],"Radiotherapy Side Effect","Pelvic Cancer",[90,91],"Artificial Intelligence","Patient-Reported Outcome","2024-10-08",{"date":94,"type":41},"2024-10-10",{"date":96,"type":41},"2024-07-22",{"date":98,"type":19},"2024-12-15",{"name":100,"class":101},"jaide","INDUSTRY",1,{"id":104,"slug":105,"hasResults":11,"nctId":106,"briefTitle":107,"officialTitle":107,"acronym":108,"eligibilityCriteria":109,"healthyVolunteers":56,"sex":15,"minAge":16,"maxAge":110,"enrollmentInfo":111,"targetDuration":4,"studyType":20,"phases":113,"briefSummary":114,"conditions":115,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":130,"locationsCount":102},"100461399","efficacy-of-the-use-of-diaries-in-intensive-care-units-100461399","NCT05288140","Efficacy of the Use of Diaries in Intensive Care Units","QUADERN","Inclusion Criteria:\n\n* admitted intensive care unit\n* sedated and mechanically ventilated for 24hours\n* signed consent\n* not language barrier\n* willingness to attend follow-up visits\n\nExclusion Criteria:\n\n* verbal manifestation of psychiatric, mental or cognitive antecedents\n* who do not coluntarily agree to participate","100 Years",{"count":112,"type":19},240,[22],"Randomized clinical trial that aims to evaluate the impact of the use of a diary in patients and relatives of patients admitted to an ICU in relation to usual practice in terms of health-related quality of life, the post-traumatic stress and anxiety\u002Fdepression at 2, 6 and 12 months after ICU discharge.",[116,117,29,118,119,120,121,122,123],"Diary (Blank Journal)","Intensive Care Unit","Family","PICS","Stress","Anxiety","Depression","Quality of Life","2024-03-26",{"date":126,"type":41},"2024-03-27",{"date":128,"type":41},"2022-01-01",{"date":71,"type":19},{"name":131,"class":48},"University of Barcelona"]